Pen5-Amino-1MQ 25 mg
A selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.
The full range
63 research compounds — each synthesised under controlled conditions, verified by reversed-phase HPLC, and shipped with a Certificate of Analysis.
PenA selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.
PenA selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.
PenA growth-hormone fragment studied for lipolysis and fat-metabolism research.
PenAn EPO-derived peptide studied for tissue protection and neuropathic-pain research.
PenA gastric pentadecapeptide studied for tissue repair and angiogenesis.
PenA bronchial peptide bioregulator studied for respiratory-tissue research.
PenA heart-derived peptide bioregulator studied for myocardial and cardiovascular research.
PenA cartilage peptide bioregulator studied for connective-tissue and joint research.
PenA GHRH analog studied for sustained growth-hormone-axis stimulation research.
PenA cortex-derived peptide bioregulator studied for neural repair and cognition research.
PenAn angiotensin-IV-derived peptide studied for synaptogenesis and cognition research.
PenDelta-sleep-inducing peptide studied for sleep and stress-response research.
PenThe 10 mg telomerase tetrapeptide pen for longevity research.
PenA pineal tetrapeptide studied for telomerase and longevity research.
PenA FOXO4–p53 disrupting peptide studied for selective senescent-cell clearance.
PenA copper-binding peptide studied for skin-remodelling and regeneration research.
PenThe higher-strength copper-peptide pen for skin-remodelling and regeneration research.
PenThe lower-strength TB-500 + BPC-157 + GHK-Cu blend for recovery and skin research.
PenA TB-500 + BPC-157 + GHK-Cu blend studied for recovery and skin-remodelling research.
PenThe master antioxidant tripeptide studied for redox balance and detoxification research.
PenHuman chorionic gonadotropin studied for the gonadal axis and steroidogenesis.
PenA gonadotropin preparation with FSH and LH activity for reproductive-axis research.
PenA long-acting IGF-1 analog studied for cell growth, repair and metabolism research.
PenA selective GHRP studied for growth-hormone release and recovery research.
PenA signalling peptide studied for the reproductive endocrine axis and GnRH release.
PenA four-peptide repair blend (TB-500, BPC-157, KPV, GHK-Cu) for recovery research.
PenA combined recovery blend — TB-500, BPC-157, KPV and GHK-Cu — in one pen.
PenAn α-MSH-derived tripeptide studied for anti-inflammatory signalling.
PenA liver-derived peptide bioregulator studied for chromatin and ageing research.
PenA cathelicidin peptide studied for antimicrobial and immune-modulation research.
PenA mitochondrial-derived peptide studied for metabolic homeostasis and exercise adaptation.
PenA mitochondrial-derived peptide studied for metabolic homeostasis and exercise adaptation.
PenThe NAD⁺ coenzyme studied for cellular energy, DNA repair and longevity research.
PenThe 500 mg NAD⁺ coenzyme pen for cellular-energy and longevity research.
PenA methylene-blue formulation studied for mitochondrial electron transport and neuro-research.
PenA neuropeptide hormone studied for social-bonding and neuroendocrine research.
PenA pancreas-derived peptide bioregulator studied for metabolic and glucose-regulation research.
PenA spadin-derived peptide studied for TREK-1 channels and mood research.
PenA short peptide bioregulator (Glu-Asp-Arg) studied for neuroprotection and brain-ageing research.
PenA p53-derived peptide studied for membrane-targeting and cancer-cell research.
PenA melanocortin-receptor agonist (bremelanotide) studied for central arousal pathways.
PenA quintuple agonist — GLP-1, GIP, glucagon, amylin & chemokine antagonism — for metabolic research.
PenA tuftsin-analogue peptide studied for anxiolytic and nootropic endpoints.
PenAn ACTH-derived peptide studied for nootropic and neuroprotective research.
PenAn ERR agonist studied as an exercise mimetic for endurance research.
PenAn ERR agonist studied as an exercise mimetic for mitochondrial biogenesis.
PenAn octapeptide studied for expression-line and skin-cosmetic research.
PenA mitochondria-targeted peptide studied for bioenergetics and cardiovascular research.
PenThe higher-strength mitochondrial peptide pen for bioenergetics research.
PenA thymosin β4 fragment studied for recovery, angiogenesis and tissue-repair models.
PenThe 10 mg GHRH-analog pen for GH-axis and visceral-fat research.
PenA GHRH analog studied for growth-hormone axis and visceral-fat research.
PenA reproductive peptide bioregulator studied for testicular-function and ageing research.
PenA thymic peptide complex studied for immune-regulation and ageing research.
PenA thymic peptide studied for immune-modulation and host-defence research.
PenA TB-500 + BPC-157 recovery blend studied for tissue repair and angiogenesis research.
PenA growth-peptide research blend studied for the GH/IGF-1 axis and recovery endpoints.
PenThe mid-strength growth-peptide blend for GH/IGF-1 axis research.
PenThe higher-strength growth-peptide blend for GH/IGF-1 axis research.
PenA vascular peptide bioregulator studied for endothelial and cardiovascular research.
PenA dipeptide bioregulator (Lys-Glu) studied for immune regulation and ageing research.
PenVasoactive intestinal peptide studied for immune-modulation and inflammatory research.
PenA TB-500 + BPC-157 recovery blend studied for tissue repair and angiogenesis research.
If you’re looking for a peptide that isn’t listed, contact the lab — we can advise on availability and batch documentation.